Announcements Trials
Browse Landscape

Phase

Phase 2 52Phase 3 20Phase 1 13Phase 1/2 8Phase NA 5Phase 2/3 3Phase 4 2

Status

Unknown 4Recruiting 3Completed 3Withdrawn 2Terminated 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 3Neoplasm Metastasis 1

Interventions

Cisplatin 22Fluorouracil 21Radiotherapy 18Gemcitabine 17Docetaxel 16Oxaliplatin 15Paclitaxel 14Carboplatin 13Capecitabine 13Bevacizumab 13Leucovorin 11Cyclophosphamide 11Irinotecan 10Drug Therapy 10Cytarabine 9Saline Solution 7Magnetic Resonance Spectroscopy 7Letrozole 7Dexamethasone 7Rituximab 6Nivolumab 6Methotrexate 6Exercise 6Etoposide 6Electroporation 6Doxorubicin 6pembrolizumab 5Pemetrexed 5Metformin 5Melphalan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Completed × Folfox protocol × Clear all
NCT00208260 2026-02-05

Intensified Chemotherapy in CRC After Resection of Liver Metastases

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 2/3 Completed
124 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03031444 2021-02-01

PARECEC

Peking University Cancer Hospital & Institute

Phase 2/3 Completed
135 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT00384176 2017-04-14

HORIZON III

AstraZeneca

Phase 2/3 Completed
1,814 enrolled 13 charts
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡